| Dr Tedd James Welniak, MD | |
|
987400 Nebraska Medical Ctr, Omaha, NE 68198-7400 | |
| (402) 559-6673 | |
| (402) 559-8333 |
| Full Name | Dr Tedd James Welniak |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 987400 Nebraska Medical Ctr, Omaha, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336433895 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 27314 (Nebraska) | Primary |
| 207P00000X | Emergency Medicine | 273535 (New York) | Secondary |
| Entity Name | Unmc Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417912114 PECOS PAC ID: 6002728391 Enrollment ID: O20031104000664 |
News Archive
Endocrinologists, primary care physicians (PCPs) and nurse educators perceive Lilly and Novo Nordisk to have the best diabetes corporate image, with Lilly slightly outscoring Novo among endocrinologists and Novo outscoring Lilly among PCPs and nurses. Results show that endocrinologists see wider differences among the diabetes companies in overall image and key performance dimensions more so than do PCPs and nurses, according to Market Strategies International's syndicated 2010 U.S. Diabetes MSImage® study.
MDS Nordion, a leading provider of products and services to the global health science market, Guerbet, a pharmaceutical group specialized in medical imaging, and Cyceron, a biomedical imaging centre in France, announced today they have entered into an agreement to develop new Positron Emission Tomography (PET) radiotracers for cancer diagnostics.
The Juvenile Diabetes Research Foundation (JDRF), the worldwide leader for research to cure, treat, and prevent type 1 diabetes, and InnoCentive, Inc., the pioneer in open innovation and crowdsourcing, today announced a $100,000 Challenge calling for innovative ways to approach the discovery and development of a glucose-responsive insulin drug as a means to treat insulin-dependent diabetes.
Today's early morning highlights from the major news organizations, including reports about the health law's effect on unions and hospitals and a new IRS ruling designed to keep employers from dumping workers onto the law's online marketplaces.
A partnership between the healthtech company Living With, the Royal United Hospitals Bath NHS Foundation Trust, and the University of Bath has been awarded a major grant to develop a Rheumatoid Arthritis Flare Profiler.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tedd James Welniak, MD 988102 Nebraska Medical Ctr, Omaha, NE 68198-8102 Ph: (402) 559-6195 | Dr Tedd James Welniak, MD 987400 Nebraska Medical Ctr, Omaha, NE 68198-7400 Ph: (402) 559-6673 |
News Archive
Endocrinologists, primary care physicians (PCPs) and nurse educators perceive Lilly and Novo Nordisk to have the best diabetes corporate image, with Lilly slightly outscoring Novo among endocrinologists and Novo outscoring Lilly among PCPs and nurses. Results show that endocrinologists see wider differences among the diabetes companies in overall image and key performance dimensions more so than do PCPs and nurses, according to Market Strategies International's syndicated 2010 U.S. Diabetes MSImage® study.
MDS Nordion, a leading provider of products and services to the global health science market, Guerbet, a pharmaceutical group specialized in medical imaging, and Cyceron, a biomedical imaging centre in France, announced today they have entered into an agreement to develop new Positron Emission Tomography (PET) radiotracers for cancer diagnostics.
The Juvenile Diabetes Research Foundation (JDRF), the worldwide leader for research to cure, treat, and prevent type 1 diabetes, and InnoCentive, Inc., the pioneer in open innovation and crowdsourcing, today announced a $100,000 Challenge calling for innovative ways to approach the discovery and development of a glucose-responsive insulin drug as a means to treat insulin-dependent diabetes.
Today's early morning highlights from the major news organizations, including reports about the health law's effect on unions and hospitals and a new IRS ruling designed to keep employers from dumping workers onto the law's online marketplaces.
A partnership between the healthtech company Living With, the Royal United Hospitals Bath NHS Foundation Trust, and the University of Bath has been awarded a major grant to develop a Rheumatoid Arthritis Flare Profiler.
› Verified 6 days ago
Tyler Christian Pedersen, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 981150 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-6802 | |
Chad E Branecki, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 988095 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-9800 Fax: 402-559-9840 | |
Dr. Robert S. Devin, M.D. Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 6901 N 72nd St, Omaha, NE 68122 Phone: 402-572-2225 Fax: 402-572-4974 | |
Dr. Kevin Michael Montgomery, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 981150 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-6802 | |
Ryan Jorgenson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 981150 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-6802 | |
Phillip Marshall Stratton, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-4424 Fax: 402-354-4435 | |
Dr. James E Quinn, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-4424 Fax: 402-354-4435 |